InvestorsHub Logo
Followers 67
Posts 1293
Boards Moderated 0
Alias Born 08/12/2014

Re: ATLnsider post# 339513

Tuesday, 12/15/2020 6:55:56 PM

Tuesday, December 15, 2020 6:55:56 PM

Post# of 701109
The adjudicated is the second secondary endpoint, "the The second secondary endpoint, confirmed progression-free survival (cPFS), is confirmed disease progression (cPD) compared between subjects randomized to DCVax®-L and those randomized to Placebo within Study 020221."

[unbelievable did I count my allowable post wrong today?]
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News